iZafe Group's Business Unit Manager, Helena Kolvik, Acquires Shares in the Company

November 17, 2025 4:15 AM

iZafe Group (STO:IZAFE-B) - iZafe Group AB (publ.) announces today that the company's Business Unit Manager, Helena Kolvik, has acquired approximately 158,500 B-shares in iZafe, corresponding to a total value of approximately SEK 100,000. The acquisitions were carried out on two occasions, last Friday and today.The acquisitions underline Helena's strong commitment to iZafe Group's operations and her confidence in the company's continued...

Read more

Innerbloom Ketamine Therapy Expands Depression Treatment in San Luis Obispo With FDA-Approved SPRAVATO

November 16, 2025 9:00 PM

Innerbloom Ketamine Therapy announces the addition of SPRAVATO® (esketamine) nasal spray to its comprehensive mental health treatment offerings, providing San Luis Obispo residents access to an FDA-approved treatment for treatment-resistant depression that can now be used with or without a daily oral antidepressant.Earlier this year, SPRAVATO® received FDA approval as the first and only medication for treating treatment-resistant depression...

Read more

President Trumps Cannabis Decision Soon: From Hemp Shutdown to Pharmaceutical Clarity: MMJ Leads Federally Legal Cannabis Drug Development

November 16, 2025 5:00 PM

As Congress moves decisively to end the era of intoxicating hemp products and synthetic cannabinoids, a new chapter is opening for federally legal cannabis based medicines. With regulatory clarity emerging from the FDA, DEA, and bipartisan state authorities, MMJ International Holdings, Inc. now stands as the U.S. company fully positioned within the federal pharmaceutical pathway for cannabis drug development. For a decade, MMJ pursued the...

Read more

Ascelia Pharma Announces FDA Acceptance of Orviglance New Drug Application for Review

November 15, 2025 6:15 AM

Ascelia Pharma AB (publ) (ticker: ACE), a biotech focused on improving the life of people living with rare cancer conditions, today announced that the U.S. Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for Orviglance® for review. The FDA has set an action date of 3 July 2026 under the Prescription Drug User Fee Act (PDUFA).The FDA has confirmed through their ‘day 74 letter' their acceptance of the NDA filing for...

Read more

Medicus Pharma Ltd. Provides Corporate Updates and Reports Third Quarter 2025 Financial Highlights

November 14, 2025 5:00 PM

Medicus Pharma Ltd. (NASDAQ:MDCX) ("Medicus" or the "Company"), a biotech/life sciences company focused on advancing the clinical development programs of novel and potentially disruptive therapeutic assets, announced today its financial and operating results for the quarter ending September 30, 2025, and highlighted important corporate updates.Third Quarter Corporate Highlights:Skinject Clinical Development Program SKNJCT-003 & SKNJCT-004...

Read more

ADM Tronics Reports Second Quarter of Fiscal Year 2026 Results

November 14, 2025 4:35 PM

ADM Tronics Unlimited, Inc. (OTCQB:ADMT), a technology-based developer and manufacturer of innovative technologies and products, announces results for its second fiscal quarter ended September 30, 2025 of Fiscal Year 2026.The Company continued its positive momentum in revenues this fiscal year, building on the gains reported in the Annual 10-K Report for the fiscal year ended March 31, 2025, and the first fiscal quarter ended June 30, 2025. For...

Read more

Tivic Reports Third Quarter 2025 Financial Results

November 14, 2025 4:30 PM

Tivic Health® Systems, Inc. (Nasdaq:TIVC), a diversified immunotherapeutics company, today announced financial results for the third quarter and nine months ended September 30, 2025 and provided a business update."Following our discussions at the Military Health System Research Symposium and continued engagement with key government agencies, we are encouraged by the interest in our lead product candidate, Entolimod for acute radiation syndrome...

Read more

Ensysce Biosciences Reports Third Quarter 2025 Financial Results

November 14, 2025 4:15 PM

Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), a clinical-stage pharmaceutical company pioneering next-generation severe pain therapeutics designed to minimize abuse and overdose risk, today reported financial and operational results for the third quarter ended September 30, 2025.Dr. Lynn Kirkpatrick, Chief Executive Officer of Ensysce, commented, "It has been another highly productive quarter as we navigate tumultuous...

Read more

CASI Pharmaceuticals Announces Third Quarter 2025 Business and Financial Results

November 14, 2025 4:05 PM

CASI Pharmaceuticals, Inc. (NASDAQ:CASI), a clinical-stage biopharmaceutical company focused on the development of CID-103, a potential best-in-class, anti-CD38 monoclonal antibody for patients with organ transplant rejection and autoimmune diseases, today reported business and financial results for the quarter ended September 30, 2025 (the "third quarter")."We are focused on capitalizing and advancing our CID-103 clinical program in renal...

Read more

Dermata Therapeutics Provides Corporate Update and Reports Third Quarter 2025 Financial Results

November 14, 2025 4:05 PM

Dermata Therapeutics, Inc. (Nasdaq:DRMA; DRMAW) ("Dermata," or the "Company"), a science-driven leader in dermatologic solutions, today highlighted recent corporate progress and reported financial results for the third quarter ended September 30, 2025."At Dermata, our mission is to bring scientifically developed innovation directly to those who need it most," said Gerry Proehl, Chairman, President, and CEO of Dermata. "Our recent strategic pivot...

Read more

Cenmed and Curavit Announce Strategic Collaboration to Streamline Clinical Trial Kitting and Logistics

November 14, 2025 3:00 PM

Cenmed, a leader in laboratory distribution and supply chain solutions, and Curavit Clinical Research, a virtual contract research organization (VCRO) specializing in decentralized clinical trials (DCTs), today announced a strategic collaboration to enhance the efficiency and scalability of kitting and logistics services for clinical research. The combination of Cenmed's expertise in customized kitting, inventory management, and distribution...

Read more

BODYWELLE Teams Up With Local Favorites for Puppy Yoga and Sound Healing in Miami Beach

November 14, 2025 2:30 PM

BODYWELLE, a physician-led longevity and wellness clinic in Miami Beach, will host Puppy Yoga & Sound Healing on Sunday, November 16, 2025, from 9:00 to 11:00 a.m. EST at 1060 Alton Road, Miami Beach. This community-focused wellness event combines restorative yoga, therapeutic sound, and medical-grade self-care experiences in partnership with Go Greek Miami, Pura Vida Miami, Black Sheep Coffee, and Dalmatian Rescue.The morning is designed to...

Read more

Relief Therapeutics Shareholders Approve Business Combination with NeuroX

November 14, 2025 12:40 PM

RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF, RLFTY) (Relief or the Company), a biopharmaceutical company committed to delivering innovative treatment options for select specialty, unmet and rare diseases, announced that shareholders approved by a large majority all resolutions submitted to its extraordinary general meeting (EGM) held earlier today in Geneva, Switzerland. The approvals authorize the business combination between Relief...

Read more

sam Wearable Ultrasound Device Helps U.S. Army Veteran Noah Galloway

November 14, 2025 12:20 PM

U.S. Army veteran Noah Galloway's journey has taken him from being gravely wounded in Iraq to the cover of Men's Health magazine to a third-place finish on "Dancing with the Stars" and a role as a national veterans' advocate. Galloway credits ZetrOZ System's sam® wearable ultrasound device for helping him manage his chronic pain and recover from years of overuse and training.Galloway, the newest ambassador for sam®, was prescribed the device...

Read more

AI Governance Helps Hospitals Turn Stalled Pilots Into Fast-Track ROI

November 14, 2025 10:45 AM

A new industry survey from Black Book Research reveals that while hospitals are rapidly piloting artificial intelligence solutions, many lack the governance structures needed to turn vendor promises into safe, scalable results.In Black Book's recent Hospital AI Governance Pulse survey of approximately 650 U.S. hospital leaders, 80% of respondents said AI vendor claims are difficult to verify without a formal AI governance program, and 70%...

Read more

VRAIKO: Redefining Skincare With the Power of the High-Altitude Calanthe Orchid

November 14, 2025 10:00 AM

Deep in the alpine forests of Yunnan, China, a delicate but powerful flower quietly thrives - the Calanthe orchid, also known as the Shrimp Orchid. Despite living in a world of constant humidity shifts and biting cold, this orchid doesn't just survive - it flourishes. Scientists have found that this rare plant owes its resilience to adaptive polysaccharides - sugar molecules that help the orchid retain moisture, support cell health, and protect...

Read more

Tom Brady 1/1 NFL Shield Autograph Card Hits Fanatics Collect Premier Auction Through Medical Care Technologies Inc. (OTC PINK:MDCE) Subsidiary Infinite Auctions

November 14, 2025 9:30 AM

Medical Care Technologies Inc. (OTC PINK:MDCE) is proud to announce that its wholly owned subsidiary, Infinite Auctions, has formed a consignment agreement with Fanatics Collect, the sports-card division of Fanatics, to feature an extraordinary one-of-one 2009 Topps Unique Tom Brady NFL Shield Patch Autograph Card in Fanatics Collect's Premier Auction. This rare collectible - graded PSA 6 EX-MT - showcases an authentic game-worn NFL Equipment...

Read more

Modular Medical Submits Pivot Tubeless Insulin Patch Pump for FDA 510(k) Clearance

November 14, 2025 9:00 AM

Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company") today announced the 510(k) premarket submission of its next generation Pivot™ tubeless patch pump to the U.S. Food and Drug Administration (the "FDA"). The Company expects to commence the commercial launch of its Pivot pump in Q1 2026.Key Investment HighlightsFeatureImpactFirst 2-part tubeless patch pump3 milliliter ("ml") removable reservoir; no battery recharge;...

Read more

Jaguar Health to Hold Investor Webcast Monday, November 17 at 8:30 AM Eastern Regarding Q3 2025 Financials & Corporate Updates

November 14, 2025 9:00 AM

Jaguar Health, Inc. (NASDAQ:JAGX) today announced that the company will conduct an investor webcast on Monday, November 17, 2025, at 8:30 a.m. Eastern to review third-quarter 2025 financials and provide corporate updates.Participation Instructions for Jaguar Investor WebcastWhen: Monday, November 17, 2025 at 8:30 AM Eastern TimeParticipant Registration & Access Link: Click HereAbout the Jaguar Health Family of CompaniesJaguar Health, Inc....

Read more

Wellgistics Health to Distribute Tollo Health GLP-1 Companion Muscle Loss Medical Food to Pharmacies & Physicians

November 14, 2025 9:00 AM

Wellgistics Health, Inc. ("Wellgistics") (NASDAQ:WGRX), a leader in the integration of physical and technology healthcare infrastructure for prescription drugs, today announced that it has expanded its agreement with Tollo Health to offer the first GLP-1 companion muscle loss medical food to its 6,500+ independent pharmacy network (‘Pharmacy Network') and physicians. The product is a branded version of a proprietary formulation that has been...

Read more